NRXP - NDA for NRX-100 (IV ketamine) in suicidal depression in advanced preparation for submission in 2024; based on four positive trials 3 4 5 6 and Fast Track Designation. Potential revenue in 2025
Upvotes: 1
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list